$XLV going to outperform $SPY (5/5)Conviction: 5/5
Health Care ( AMEX:XLV ) is looking very attractive relative to S&P 500 ( AMEX:SPY ), just bounced off of long-term (2022) support on a relative basis.
RSI-M at oversold levels (obviously), while RSI-W seems to have put in a bullish divergence?
Let's see which channel wins, but I think long-term one is stronger.